Cargando…
Mitophagy in atherosclerosis: from mechanism to therapy
Mitophagy is a type of autophagy that can selectively eliminate damaged and depolarized mitochondria to maintain mitochondrial activity and cellular homeostasis. Several pathways have been found to participate in different steps of mitophagy. Mitophagy plays a significant role in the homeostasis and...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10228545/ https://www.ncbi.nlm.nih.gov/pubmed/37261351 http://dx.doi.org/10.3389/fimmu.2023.1165507 |
_version_ | 1785050988589088768 |
---|---|
author | Zhang, Yanhong Weng, Jiajun Huan, Luyao Sheng, Song Xu, Fengqin |
author_facet | Zhang, Yanhong Weng, Jiajun Huan, Luyao Sheng, Song Xu, Fengqin |
author_sort | Zhang, Yanhong |
collection | PubMed |
description | Mitophagy is a type of autophagy that can selectively eliminate damaged and depolarized mitochondria to maintain mitochondrial activity and cellular homeostasis. Several pathways have been found to participate in different steps of mitophagy. Mitophagy plays a significant role in the homeostasis and physiological function of vascular endothelial cells, vascular smooth muscle cells, and macrophages, and is involved in the development of atherosclerosis (AS). At present, many medications and natural chemicals have been shown to alter mitophagy and slow the progression of AS. This review serves as an introduction to the field of mitophagy for researchers interested in targeting this pathway as part of a potential AS management strategy. |
format | Online Article Text |
id | pubmed-10228545 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-102285452023-05-31 Mitophagy in atherosclerosis: from mechanism to therapy Zhang, Yanhong Weng, Jiajun Huan, Luyao Sheng, Song Xu, Fengqin Front Immunol Immunology Mitophagy is a type of autophagy that can selectively eliminate damaged and depolarized mitochondria to maintain mitochondrial activity and cellular homeostasis. Several pathways have been found to participate in different steps of mitophagy. Mitophagy plays a significant role in the homeostasis and physiological function of vascular endothelial cells, vascular smooth muscle cells, and macrophages, and is involved in the development of atherosclerosis (AS). At present, many medications and natural chemicals have been shown to alter mitophagy and slow the progression of AS. This review serves as an introduction to the field of mitophagy for researchers interested in targeting this pathway as part of a potential AS management strategy. Frontiers Media S.A. 2023-05-16 /pmc/articles/PMC10228545/ /pubmed/37261351 http://dx.doi.org/10.3389/fimmu.2023.1165507 Text en Copyright © 2023 Zhang, Weng, Huan, Sheng and Xu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Zhang, Yanhong Weng, Jiajun Huan, Luyao Sheng, Song Xu, Fengqin Mitophagy in atherosclerosis: from mechanism to therapy |
title | Mitophagy in atherosclerosis: from mechanism to therapy |
title_full | Mitophagy in atherosclerosis: from mechanism to therapy |
title_fullStr | Mitophagy in atherosclerosis: from mechanism to therapy |
title_full_unstemmed | Mitophagy in atherosclerosis: from mechanism to therapy |
title_short | Mitophagy in atherosclerosis: from mechanism to therapy |
title_sort | mitophagy in atherosclerosis: from mechanism to therapy |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10228545/ https://www.ncbi.nlm.nih.gov/pubmed/37261351 http://dx.doi.org/10.3389/fimmu.2023.1165507 |
work_keys_str_mv | AT zhangyanhong mitophagyinatherosclerosisfrommechanismtotherapy AT wengjiajun mitophagyinatherosclerosisfrommechanismtotherapy AT huanluyao mitophagyinatherosclerosisfrommechanismtotherapy AT shengsong mitophagyinatherosclerosisfrommechanismtotherapy AT xufengqin mitophagyinatherosclerosisfrommechanismtotherapy |